Martin C.b. Mellish
CIK: 0001992320
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Mellish Martin C.B.
Mellish Martin C.B. (SEC CIK 0001992320) files insider reports with the SEC as Director of NuCana plc (NCNA) and Director of Spectral AI, Inc. (MDAI).
Signal8 holds 3 ownership filings by Mellish Martin C.B. (1 Form 3, 2 Form 4), filed between Apr 30, 2025 and Mar 20, 2026. Those filings report 2 transactions, from Apr 30, 2025 to Jun 4, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Mellish Martin C.B.'s filings is in EDINBURGH.
Recent filings by Mellish Martin C.B.
Other insiders filing for NuCana plc (NCNA)
- Levy Elliott M., Director
- Bloss Jeffrey D., Chief Medical Officer
- Bruce Theresa Margaret Ms, Chief Operating Officer
- Harrison David James, Head of Translational Medicine
- Webster Ian Alexander
- Kay Andrew Martin, Director